Supreme Court pregabalin hearing to have a big impact on UK pharma patent rights

Next week’s UK Supreme Court hearing on the long-running patent dispute over pregabalin will be watched closely by life sciences innovators.

The final ruling should help clarify the role of ‘plausibility’ in determining the sufficiency of patent…

Unlock unlimited access to all IAM content